Subcutaneous Immunoglobulin (IgPro20) Dose Adjustments for Chronic Inflammatory Demyelinating Polyneuropathy Maintenance Therapy in Clinical Practice (P10-11.024)
To assess dosing of IgPro20 (immune globulin subcutaneous [human], 20% liquid, Hizentra®) in clinical practice in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
Authors
- Tuan Vu (ORCID: https://orcid.org/0000-0003-0724-0210)
- Nan Jiang (ORCID: https://orcid.org/0000-0002-7661-5728)
- Amanda Peltier (ORCID: https://orcid.org/0000-0003-1097-7715)
- Khema R. Sharma
- Michael Pulley (ORCID: https://orcid.org/0000-0003-1879-725X)
- Sami Khella
Institutions
- University of Miami (US)
- University of South Florida (US)
- University of Alabama at Birmingham (US)
- University of Florida (US)
- University of Pennsylvania (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000209001
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00